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Abstract 
We have investigated the regulation of tyrosine proteins phosphorylation by intracellular Ca*’ level ([Ca”Ji) and protein kinase C (PKC) during 
platelet stimulation. We found that chelation of extracellular calcium completely prevented phosphorylation of tyrosine proteins induced by 
thapsigargin and phorboll2-myristate 13-acetate (PMA), whereas, when induced by thrombin, it prevented a subset of tyrosine proteins. The selective 
inhibition of PKC by GF 109203X did not abolish tyrosine protein phosphorylation when induced by thrombm and thapsigargin. The results suggest 
that in human platelets tyrosine protein phosphorylation is dependent on [Ca2yi, although direct PKC activation can also induce phosphorylation 
of tyrosine proteins. 
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1. Introduction 
Platelet activation occurs through a rise of cytoplas- 
mic Ca” level, and this Ca” mobilisation is accompa- 
nied by the activation of a number of kinases among 
which the serine/threonine protein kinase C (PKC) and 
tyrosine protein kinases. Tyrosine protein phosphoryla- 
tions are observed during platelet activation by thrombin 
[l-3], ionophore A23 187 and PKC activators [4], thapsi- 
gargin [5] and P256, an anti-glycoprotein IIb-IIIa (inte- 
grin a,,,,&) monoclonal antibody [6]. These phosphoryla- 
tions are dependent on tyrosine protein kinases such as 
pp60”“’ [l-2,7], ~~125~~~ [8] and ~72~~ [9]. It is not 
clearly established whether tyrosine kinases depend on 
Ca2’ mobilisation [5], on PKC activation [lo] or on both 
[4]. This prompted us to further specify the regulation of 
phosphorylation of tyrosine proteins. For this purpose, 
we compared the profiles of tyrosine protein phosphoryl- 
ation induced by thrombin, a receptor-dependent ag- 
onist, phorbol 1Zmyristate 13-acetate (PMA), a direct 
activator of PKC, and thapsigargin which increases the 
concentration of cytoplasmic free Ca2+ by specific inhibi- 
tion of the dense tubular system Ca”-ATPase [ 1 l-131 
independently of the generation of inositol phosphates 
1141. 
We compared the Ca2+ mobilisation induced by these 
*Corresponding author. (33) (1) 44 07 17 72. 
Abbreviations: [Ca*+li, intracelhdar calcium level; EDTA, ethylenedi- 
aminetetraacetic acid; 5-HT, 5-hydroxytryptamine; Indol-AM, indol 
acetoxymethyl ester; PKCI, protein kinase C inhibitor GF 109203X, 
PMA, phorbol 12-myristate 13-acetate; PRP, platelet-rich plasma; 
SDS, sodium dodecyl sulfate. 
three agonists and its relationship with PKC and tyrosine 
protein kinase activation in the presence of Ca2’ and 
PKC inhibitors. Our results demonstrate that phospho- 
rylation of tyrosine proteins is dependent on Ca” mobil- 
isation and occurs downstream of PKC only when PKC 
is directly activated. 
2. Materials and methods 
Human platelets were isolated on metrixamide gradient as described 
in [lo]. Platelet aggregation and release were monitored using a Chrono 
Log (Coultronics, Margency, France) aggregometer and [14C]5-HT la- 
belled platelets in the presence of 1 PM imipramine. 
Protein phosphorylation of [“‘Plorthophosphate labelled platelets 
was detected by autoradiography after electrophoresis using a 13% 
polyacrylamide gel under reducing conditions. Tyrosine phosphoryla- 
tion was detected by electrophoresis using a 7% polyacrylamide gel 
under reducing conditions and Western blotting [lo]. Blots were incu- 
bated with a monoclonal anti-phosphotyrosine antibody 4G10 (1.5 
~&nl) for 1 h, with a goat anti-mouse antibody (2 ~&nl) linked to 
peroxydase (Amersham, Les Ulis, France) for 1 h, and developed with 
4chloro I-naphtol. 
[Ca*“k measurements were performed on indol-labelled platelets. 
Indol fluorescence was recorded using a spectrofluorimeter (LS50, 
Perkin-Elmer Cetus Instruments, Norwalk, USA) with a temperature- 
controlled cuvette (37°C). Excitation and emission wavelengths were 
331 nm and 410 mn, respectively. Intracellular free calcium ([Ca*‘]J was 
calibrated according to the derivation of Grynkiewicz et al. [15]. Briefly, 
[Ca”], = K,(F - F&/(F_ - FJ where Fti and F_ are the fluores- 
cence intensities obtained without external Ca” and at saturating C?a*+, 
respectively, and F is the measured fluorescence intensity. & for 
indol at 37°C was taken to be 250 nM. 
2.1. Materials and chemicals 
Thapsigargin, PMA, imipramine and indol acetoxymethyl ester 
@idol-AM) were purchased from Sigma (Saint Quentin Fallavier, 
France). Bovine thrombin was from Hoffmann La Roche (Basel, Swit- 
zerland). [‘4C]5-hydroxytryptamine @‘C]S-HT), and [“P]ortho- 
phosphate were from Amersham (Les Ulis, France), and metrixamide 
was from Nycomed AS (Oslo, Norway). The PKC inhibitor bisin- 
dolylmaleimide GF 109203X was a kind gift from Dr. Coste (Labora- 
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toires Glaxo, Les Ulis, France) [16], and the monoclonal anti- 
phosphotyrosine antibody 4GlO from Dr. Druker (Boston, USA) [17]. 
3. Results and diicussion 
3.1. Protein tyrosine phosphorylation induced by 
thrombin, thapsigargin and PMA 
Fig. 1 shows that thrombin (0.1 U/ml) causes the in- 
crease in phosphorylation of several tyrosine proteins. 
Proteins with molecular masses of 56, 60, 64, 75, 80, 85, 
97-105, 125 and 140 kDa have been identified by SDS/ 
polyacrylamide gel and immunoblot analysis using the 
same phosphotyrosine-specific antibody as previously 
described [6]. With EDTA (1 mM), the aggregation-de- 
pendent 97-105 kDa doublet [lo] and some other pro- 
teins were missing. Only the 140 kDa tyrosine protein 
phosphorylation was enhanced suggesting that a Ca2’- 
dependent phosphatase was inhibited [ 181. Bisin- 
dolylmaleimide GF 109203X (PKCI), a potent and selec- 
tive inhibitor of PKC [16], did not inhibit the profile of 
phosphotyrosine proteins either in resting (result not 
shown) or in thrombin-induced platelets. Worthy of note 
is that the 64 kDa phosphotyrosine protein was en- 
hanced in the presence of GF 109203X. Thapsigargin 
(100 nM), a platelet agonist which elevates [Ca2+]i by 
specific inhibition of the dense tubular system Ca*‘- 
ATPase [ 111, also induced tyrosine protein phosphoryla- 
tions. This response was independent of thromboxane A2 
production (40% aggregation with 1 mM aspirin), and of 
activation of phospholipase C as assessed by absence of 
phosphatidic acid production (result not shown), in 
agreement with previous results obtained in NG115- 
401 L neuronal cells [ 141. Thapsigargin induced a similar 
profile of phosphotyrosine proteins to that obtained with 
thrombin, however it was completely inhibited by 
EDTA. As for thrombin, GF 109203X had no inhibitory 
effect, and even enhanced the 64 kDa phosphotyrosine 
Resting Tbrombin Thapsigsrgin PMA 
- EDTA PKCI - EDTA PKCI - EDTA PKCI 
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Fig. 1. Effect of EDTA and GF 109203X on trombin-, thapsigargin- 
and PMA-induced tyrosine protein phosphorylation in human plate- 
lets. Platelets were preincubated with CaCl, (1 mM) and stimulated for 
2 mitt in the presence of GF 109203X (PKCI 5 PM) or EDTA (1 mM 
without CaC13 with thrombin (0.1 U/ml), thapsigargin (100 nM) or 
PMA (200 nM) as indicated. The samples were analyzed by anti- 
phosphotyrosine immunoblotting. 
- EDTA PKCI - EDTA PKCI - EDTA PKCI 
Thmmbin Thapsigargin PMA 
Fig. 2. Effect of EDTA and GF 109203X on trombin-, thapsigargin- 
and PMA-induced aggregation and [“‘Cl5-HT release. [i4C]5-HT-la- 
belled platelets were preincubated for 5 min in the presence of imipram- 
ine (1 PM) before addition of CaCl, (1 mM), and of thrombin (0.1 
U/ml), thapsigargin (100 nM) or PMA (200 nM) for 2 min. GF 
109203X (PKCI 5 PM) or EDTA (1 mM without CaC13 was added 1 
min before activation as indicated. Values are the mean of 3 to 6 
experiments. Detailed conditions are described in section 2. 
protein. PMA (200 nM), a direct activator of PKC, in- 
duced the same profile of tyrosine protein phosphoryla- 
tions as did thrombin and thapsigargin [lo]. However, 
these phosphorylations were completely inhibited in the 
presence of both EDTA and GF 109203X. Thus, with all 
three agonists, we found that external Ca*’ is essential 
for tyrosine protein phosphorylation, suggesting that in- 
tracellular Ca” is predominant over PKC for tyrosine 
kinase activity in human platelets. 
3.2. Aggregation and secretion induced by thrombin, 
thapsigargin and PMA 
Thrombin, thapsigargin and PMA induced platelet ag- 
gregation and 5-HT release from dense granules as meas- 
ured by release of [14C]5-HT (Fig. 2). With all three 
agonists, GF 109203X ( 5 PM) prevented [i4C]5-HT re- 
lease. This conIirmed that activation of PKC is necessary 
for platelet granule secretion [19]. Addition of EDTA (1 
mM) prevented aggregation and reduced basal [Ca2’li 
and had only a limited effect on thrombin-induced re- 
lease. It prevented thapsigargin-induced aggregation and 
[14C]5-HT release. In this case, Ca*’ entry is essential for 
thapsigargin-induced PKC activation, and thus chela- 
tion of external Ca2+ prevented secretion, RGDS pep- 
tide, a specific inhibitor of platelet aggregation did not 
modify [14C]5-HT release (result not shown). 
3.3. Effects of EDTA and GF 109203X on thrombin- 
induced activation 
Thrombin (0.1 U/ml) led to the phosphorylation of the 
47 kDa protein called pleckstrin (P47), used as a marker 
for PKC activation, and the 20 kDa protein recognized 
as the myosin light chain (P20), phosphorylated by the 
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Ca”-calmodulin dependent myosin light chain kinase 
[20] (Fig. 3A). GF 109203X (5 ,uM), inhibited thrombin- 
induced pleckstrin phosphorylation, whereas EDTA (1 
mM) had no effect on pleckstrin phosphorylation. Using 
indo 1 -1abelled platelets, thrombin (0.1 U/ml) induced an 
increase of [Ca2’]i from 116 f 6 nM to a maximum of 
434 f 26 nM (mean f S.E.M., n = 12) (Fig. 3B). Re- 
moval of extracellular calcium by addition of EDTA (1 
mM) significantly reduced the basal [Ca2+]i to 55 f 3 nM, 
as previously described [21], and also the thrombin-in- 
duced [Ca”]i rise to 155 f 13 nM (mean f S.E.M., 
n = 10). In agreement with a previous report [22], Ca2+ 
mobilisation was not decreased by the selective inhibi- 
tion of PKC. 
3.4. Effects of EDTA and GF 109203X on thapsigargin- 
induced activation 
Thapsigargin (100 nM) led to the phosphorylation of 
both pleckstrin and myosin light chain [23]. These 
phosphorylations were independent of thromboxane, 
since, in the presence of aspirin, phosphorylation of pro- 
teins was not detectable before 45 s of thapsigargin acti- 
vation, compared to 15 s in the absence of aspirin. 
Thapsigargin also induced an increase of the [Ca2+]i up 
to 398 + 32 nM (mean f S.E.M., n = ll), although 
slower than with thrombin (Fig. 4). EDTA inhibited 
thapsigargin-induced [Ca2’]i rise which was of only 
89 + 10 nM (mean + S.E.M., n = 10) after 3 min. EDTA 
also inhibited thapsigargin-induced pleckstrin and 
myosin light chain phosphorylation, suggesting that in 
this case a threshold [Ca2’]i was determinant for both 
myosin light chain kinase and PKC activation. Among 
the three different isoforms of PKC described in plate- 
lets, PKC6 isozyme is not Ca’+-sensitive, and the classi- 
cal isozymes PKC-& and -/I are dependent on Ca2’ and 
89 
diacylglycerol synergistically [24-251. In the case of tha- 
psigargin there was no production of diacylglycerol, 
PKC activity was thus stimulated by the only Ca2’ mo- 
bilisation. As a result, in the presence of EDTA, it was 
inactive. Moreover, as for thrombin, thapsigargin-in- 
duced Ca2+ mobilisation was not decreased by the selec- 
tive inhibition of PKC. 
3.5. Effects of EDTA and GFlO9203X on PMA-induced 
activation 
PMA (200 nM) induced a strong phosphorylation of 
pleckstrin, and to a smaller extent phosphorylation of 
the myosin light chain, without causing any [Ca”], rise 
(Fig. 5). EDTA did not affect PMA induced pleckstrin 
phosphorylation, but slightly inhibited that of the 
myosin light chain. GF 109203X inhibited PMA-induced 
pleckstrin and myosin light chain phosphorylation. In- 
deed, the phosphorylation of myosin light chain is also 
dependent on PKC [26]. 
3.6. Conclusion 
Thus, the addition of EDTA reduced protein tyrosine 
phosphorylation, induced by all three agonists. These 
results suggest that platelet tyrosine kinase activity is 
controlled by intracellular Ca”. Also when PKC was 
selectively inhibited, tyrosine protein phosphorylation 
was not abolished in the case of thrombin and thapsi- 
gargin-induced stimulation, suggesting that only Ca2’ 
entry was responsible for tyrosine protein phosphoryla- 
tion, independently of PKC activation. In cultured 
human epidermal keratinocytes, a rapid Ca2+ mobilisa- 
tion was proposed to stimulate a phosphatase activity 
resulting in pp60”’ kinase activity [27]. Indeed, this 
phosphatase dephosphorylates Tyr-527 the carboxy-ter- 
minal phosphotyrosine residue reported to be responsi- 
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Fig. 3. Effect of EDTA and GF 109203X on thrombin-induced protein phosphorylation and [Ca*‘], rises. [“?]orthophosphate (panel A) or 
indol-AM-labelled platelets (panel B) were preincubated with CaCl, (1 mM) and stimulated for 2 min with thrombin (0.1 U/ml) in the presence of 
GF 109203X (PKCI 5 PM) or EDTA (1 mM without CaCl& Autoradiograms are representative of 4 experiments. 
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Fig. 4. Effect of EDTA and GF 109203X on thapsigargin-induced protein phosphorylation and [Caz+li rises. [32P]orthophosphate- (panel A) or 
indo I-AM-labelled platelets (panel B) were preincubated with CaCl, (1 mM) and stimulated for 2 min with thapsigargin in the presence of GF 109203X 
(PKCI 5 PM) or EDTA (1 mM without CaC13 (100 nM). Autoradiograms are representative of 4 experiments. 
ble for the down-regulation of pp60”“” protein tyrosine 
kinase activity [28]. Since ~~60”“” is the most representa- 
tive protein tyrosine kinase in platelets [29], a similar 
regulation could occur in human platelets. However 
PMA could also induce tyrosine protein phosphoryla- 
tion [lo]. In this case, the phosphorylation of the Ser-12 
of the pp60”“’ protein tyrosine kinase could be implied, 
which would elevate the atiity of the kinase for its 
substrates [30]. 
tion. Ca2’ mobilisation is, however, essential for tyrosine 
protein kinase activation in human platelets. 
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